"The area where GenAI has the most potential is MLR
and it's exciting to see Veeva embrace that with MLR Bot." - Dr. Samin Saeed, Vice President, Early Assets Medical, GSK
and it's exciting to see Veeva embrace that with MLR Bot." - Dr. Samin Saeed, Vice President, Early Assets Medical, GSK
Hear Dr. Samin Saeed at GSK discuss the medical affairs evolution, the explosion of GenAI in the industry and the specific use cases where it can be the most impactful.
More Customer Stories
Otsuka’s Launch: 90 Days to Personalize Customer Content Using Modular
Read Customer Story
Read Customer Story
GSK: Why MLR Teams Are Putting Claims Back on the Map
Watch Videos
Watch Videos
BioMarin on How to Scale Customer-Centric Content for Omnichannel
Read Blog
Read Blog